Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Federal Trade Commission
McKesson
Colorcon
QuintilesIMS
Argus Health
Moodys
US Army
Novartis
Fuji

Generated: January 21, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,017,615

« Back to Dashboard

Summary for Patent: 4,017,615
Title: Propylene carbonate ointment vehicle
Abstract:An ointment vehicle containing from 0.5 to 30 percent propylene carbonate, from 30 to 99.5 weight percent petrolatum and/or polysiloxane, compatible cosolvent, the concentration of which in combination with propylene carbonate is from 0.5 to 70 percent, and, optionally, surfactants, thickeners, preservatives, and penetrants. This ointment is a suitable vehicle for all types of therapeutic agents for topical application including antibiotics, steroids, antihistamines, antiseptics, anesthetics, antibacterials, fungicides and the like, and has shown particular advantages with anti-inflammatory topical corticoids.
Inventor(s): Shastri; Subramaniam (Cupertino, CA), Shaikh; Zafaruzzaman I. (Palo Alto, CA)
Assignee: Syntex Corporation (Panama, PM)
Application Number:05/639,740
Patent Claim Types:
see list of patent claims
Compound;

Drugs Protected by US Patent 4,017,615

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 4,017,615

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 310948 ➤ Subscribe
Australia 3322871 ➤ Subscribe
Belgium 774489 ➤ Subscribe
Canada 989306 ➤ Subscribe
Switzerland 566783 ➤ Subscribe
Germany 2153779 ➤ Subscribe
Denmark 129766 ➤ Subscribe
Spain 396479 ➤ Subscribe
Spain 423345 ➤ Subscribe
Finland 52811 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Moodys
Cantor Fitzgerald
QuintilesIMS
Baxter
Argus Health
Cerilliant
Fish and Richardson
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot